Arylsulfatase A in urine of patients with urothelial tumors.
A significant increase in urine arylsulfatase A activity (p less than 0.01) was found in patients with urothelial tumors. Arylsulfatase A activity was 1.36 +/- 1.10 U/24-h urine in control specimens, 1.90 +/- 1.66 U/24-h urine in various genitourinary tract disorders, and 3.90 +/- 1.98 U/24-h urine in transitional cell carcinoma specimens. Surgical treatment of the neoplastic patients lowered the arylsulfatase A activity found in urine to within reference values. The arylsulfatase A excreted by patients with these tumors was highly sensitive to thermal inactivation while the enzyme activity in the control urines was less affected by the heat treatment. The time course of the arylsulfatase A reaction with 4-nitrocatechol sulfate was not linear in normal individuals, while it was linear in 90% of patients with urothelial tumors. This difference in the kinetic pattern of the enzyme could be used to increase the diagnostic specificity of the determination.
D000328:Adult; D000368:Aged; D002553:Cerebroside-Sulfatase / Q000652:urine*; D004795:Enzyme Stability; D005260:Female; D006358:Hot Temperature; D006801:Humans; D007680:Kidney Neoplasms / Q000201:enzymology*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000201:enzymology*; D014570:Urologic Diseases / Q000652:urine
D002553:Cerebroside-Sulfatase